ArticleBMC psychiatry2025
Prevalence and correlates of overweight and obesity in patients with major depression accompanied by abnormal TSH levels.
Article in BMC psychiatry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAbnormal thyroid function is common in patients with major depressive disorder (MDD), which may be closely associated with metabolic disturbances, especially overweight and obesity. This study aimed to examine the prevalence of overweight and obesity and their related factors in MDD patients with elevated thyroid stimulating hormone (TSH) levels.
methodsA total of 1718 patients with MDD were recruited in this study. Hamilton Anxiety Rating Scale (HAMA), Hamilton Depression Rating Scale (HAMD), and Positive and Negative Syndrome Scale (PANSS) positive subscale were used to assess clinical symptoms. In addition, free triiodothyronine (FT3), free thyroxine (FT4), thyroid stimulating hormone (TSH), anti-thyroglobulin (A-TG), body weight, height, and blood pressure were measured.
resultsMDD patients with elevated TSH levels had a higher rate of obesity and overweight compared to those without abnormal TSH levels. Among patients with elevated TSH levels, those who were overweight and obese had an older actual age and age of onset, lower A-TG levels, and higher systolic blood pressure than those who were not overweight and obese. Further logistic regression analysis showed that being married (OR: 1.582, 95% CI: 1.191-2.102) and having no suicidal behavior (OR: 1.444, 95% CI: 1.079-1.934) were independently associated with overweight and obesity in patients with elevated TSH level (p < 0.05).
conclusionPatients with MDD who have elevated TSH levels are more likely to be obese and overweight. Actual age, age of onset, systolic blood pressure, A-TG levels, marital statusand and suicidal behavior were associated with obesity and overweight in MDD patients with elevated TSH levels.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.